Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

All Activity

This stream auto-updates

  1. Yesterday
  2. Last week
  3. To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html Key Inclusions § A detailed assessment of the current market landscape of endocannabinoid system targeted therapeutics, providing information on phase of development (clinical, preclinical, and discovery stage) of lead candidates, target therapeutic area (s), route of administration (oral, topical, sublingual, oromucosal, inhalation and others), dosing frequency (once daily, twice daily, thri
  4. Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids. To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannab
  5. Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “ covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html Key Market Insights § More than 65 industry players across the world are presently engaged in evaluating the clinical applications of over180 cannabinoid-derivatives that
  6. So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions Roots Analysis is pleased to announce the publication of its recent study, titled, Endocannabinoid System Targeted Therapeutics Market, 2020-2030 The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of endocannabinoid system targeting drugs, over the next decade. Th
  7. So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions London Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings. Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients
  8. To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html Key Inclusions § A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory), type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), route of administrati
  9. Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and B7-H3) and stimulatory receptors (OX40, ICOS, GITR, 4-1BB and CD40), which are being investigated as potential targets for therapy development. Further, studies of combinatorial immune checkpoint blockade / co-stimulation, targeting newly identified checkpoints along with known checkpoint inhibitor therapies, have demonstrated promising clinical outcomes as well. To order this 350+ page report, which features 140+ figures and
  10. Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 350+ page report, which features 140+ figures and 170+ tables, please visit this link Key Market Insights § More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation immune checkpoint modulators for the treatment of multiple disease indications § The
  11. Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It feat
  12. Here, We discuss the best steps for SBCGlobal Server Settings in your Outlook Account:- Incoming Server - IMAP imap.mail.att.net is the server of IMAP 993 is the port number SSL/TLS is the security of incoming server Your SBCGlobal account email address - username Password- Your SBCGlobal account Outgoing Server - SMTP smtp.mail.att.net is the server of SMTP 465 is the port SSL/TLS is the security of Outgoing server. Your SBCGlobal account email address - username Password- Your SBCGlobal account Above given are the deta
  13. To order this 500+ page report, which features 90+ figures and 160+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html Key Inclusions § A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers and analysis based on a number of relevant parameters, such as year of establishment, company size, geographical location, type of device (autoinjectors, microneedle patches, jet injectors, dry powder inhalers, microinjectors, nasal delivery systems,
  14. Of late, there has been an evident shift in interest to non-invasive immunization methods, which include oral, intranasal and transdermal modes of administration. Currently, many biopharmaceutical companies and clinical research institutes are engaged in the development of novel vaccine delivery systems, taking into consideration the specific requirements of large scale immunization initiatives. As a result, significant efforts have been put into the development of drug delivery technologies / devices, such as microneedle patches, electroporation-based needle free injection systems, jet inject
  15. Roots Analysis has done a detailed study on “Novel Vaccine Delivery Devices Market, 2019-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 500+ page report, which features 90+ figures and 160+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html Key Market Insights § Over 130 novel vaccine delivery devices, including marketed / under development products, are being investigated for the delivery of both liquid and solid formulation
  16. Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030”. The report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years. Amongst other elements, the report includes:
  17. To order this detailed 290+ page report, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html Key Inclusions § A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider (industry and non-industry), year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling (protein identification, protein quantification, protein separation, protein extraction and protein purification), service(s) offered for proteome pro
  18. With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis. To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html The USD 16 billion (by 2030) financial opportunity wi
  19. Roots Analysis has done a detailed study on Proteome Profiling Services Market, 2020-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html Key Market Insights § Over 200 players situated across the globe, claim to offer a variety of services for proteome profiling, and have developed the required expertise to process different sample types
  20. Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.” The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the
  21. To order this 550+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html Key Inclusions § A detailed review of the overall landscape of companies that are engaged in the manufacturing of cell-based therapies, including information on the type of cells manufactured (including immune cells (including T cells, dendritic cells, NK cells), stem cells (including adult stem cells, human embryonic stem cells and induced pluripotent stem cells) and others), source of cells (autologous and allogeneic), scale of manufact
  1. Load more activity
×
  • Create New...